Abbott showcases expanding evidence across its cancer diagnostics portfolio at ASCO 2026 (opens in new tab)

Data highlight how screening and diagnostics enable earlier detection, more precise treatment decisions, and improved patient outcomes from risk to remission New MRD data from the PARTNER study...